Halozyme Therapeutics Inc (NASDAQ:HALO)

17.45
Delayed Data
As of May 22
 +0.20 / +1.16%
Today’s Change
7.26
Today|||52-Week Range
17.63
+80.83%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 20.00, with a high estimate of 26.00 and a low estimate of 6.00. The median estimate represents a +14.61% increase from the last price of 17.45.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.12
Sales
$18.7M
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -200.35%
 
 
 
 
 
 
Growthannually 15.68%
 
 
 
 
 
 

Sales

Growthquarterly -38.33%
 
 
 
 
 
 
Growthannually 22.81%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account